SG Americas Securities’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.75M | Sell |
83,024
-63,939
| -44% | -$3.5M | ﹤0.01% | 1113 |
|
|
2026
Q1 | $8.3M | Sell |
146,963
-211,415
| -59% | -$12.3M | 0.01% | 852 |
|
|
2025
Q4 | $21.3M | Buy |
358,378
+343,247
| +2,269% | +$18.7M | 0.03% | 486 |
|
|
2025
Q3 | $819K | Sell |
15,131
-228,316
| -94% | -$13.1M | ﹤0.01% | 1662 |
|
|
2025
Q2 | $13.4M | Buy |
243,447
+150,206
| +161% | +$8.85M | 0.06% | 252 |
|
|
2025
Q1 | $6.59M | Buy |
93,241
+87,789
| +1,610% | +$5.91M | 0.02% | 402 |
|
|
2024
Q4 | $358K | Sell |
5,452
-818
| -13% | -$54.8K | ﹤0.01% | 1638 |
|
|
2024
Q3 | $441K | Sell |
6,270
-1,134
| -15% | -$94.8K | ﹤0.01% | 1798 |
|
|
2024
Q2 | $610K | Sell |
7,404
-28,078
| -79% | -$2.34M | ﹤0.01% | 1564 |
|
|
2024
Q1 | $3.1M | Buy |
+35,482
| New | +$3.18M | 0.01% | 715 |
|
|
2023
Q4 | – | Sell |
-4,957
| Closed | -$439K | – | 3118 |
|
|
2023
Q3 | $439K | Sell |
4,957
-2,893
| -37% | -$257K | 0.01% | 1861 |
|
|
2023
Q2 | $680K | Buy |
7,850
+4,919
| +168% | +$463K | 0.01% | 1259 |
|
|
2023
Q1 | $285K | Sell |
2,931
-9,614
| -77% | -$997K | ﹤0.01% | 2153 |
|
|
2022
Q4 | $1.3M | Buy |
12,545
+10,832
| +632% | +$1.02M | 0.02% | 805 |
|
|
2022
Q3 | $145K | Sell |
1,713
-27,364
| -94% | -$2.44M | ﹤0.01% | 2573 |
|
|
2022
Q2 | $2.41M | Sell |
29,077
-38,363
| -57% | -$3.05M | 0.03% | 637 |
|
|
2022
Q1 | $5.2M | Buy |
67,440
+37,740
| +127% | +$3.16M | 0.04% | 403 |
|
|
2021
Q4 | $2.62M | Buy |
29,700
+28,152
| +1,819% | +$2.32M | 0.01% | 876 |
|
|
2021
Q3 | $120K | Sell |
1,548
-5,953
| -79% | -$470K | ﹤0.01% | 3578 |
|
|
2021
Q2 | $626K | Sell |
7,501
-4,007
| -35% | -$318K | ﹤0.01% | 1841 |
|
|
2021
Q1 | $869K | Sell |
11,508
-6,156
| -35% | -$503K | ﹤0.01% | 1645 |
|
|
2020
Q4 | $1.55M | Sell |
17,664
-43,792
| -71% | -$3.47M | 0.01% | 1250 |
|
|
2020
Q3 | $4.68M | Sell |
61,456
-26,112
| -30% | -$2.64M | 0.03% | 372 |
|
|
2020
Q2 | $10.8M | Buy |
87,568
+76,441
| +687% | +$7.6M | 0.09% | 157 |
|
|
2020
Q1 | $940K | Sell |
11,127
-3,184
| -22% | -$274K | 0.01% | 1346 |
|
|
2019
Q4 | $1.21M | Sell |
14,311
-83,111
| -85% | -$6.28M | 0.01% | 1137 |
|
|
2019
Q3 | $6.57M | Buy |
97,422
+82,669
| +560% | +$6.37M | 0.05% | 362 |
|
|
2019
Q2 | $1.26M | Buy |
14,753
+931
| +7% | +$79.6K | 0.01% | 1284 |
|
|
2019
Q1 | $1.23M | Buy |
+13,822
| New | +$1.28M | 0.01% | 1149 |
|
|
2018
Q4 | – | Sell |
-28,094
| Closed | -$2.72M | – | 3059 |
|
|
2018
Q3 | $2.72M | Buy |
28,094
+18,988
| +209% | +$1.9M | 0.02% | 932 |
|
|
2018
Q2 | $858K | Buy |
9,106
+1,327
| +17% | +$116K | 0.01% | 1587 |
|
|
2018
Q1 | $631K | Buy |
7,779
+1,025
| +15% | +$88K | 0.01% | 1722 |
|
|
2017
Q4 | $602K | Buy |
6,754
+5,168
| +326% | +$449K | 0.01% | 1724 |
|
|
2017
Q3 | $148K | Sell |
1,586
-347
| -18% | -$30.7K | ﹤0.01% | 2850 |
|
|
2017
Q2 | $176K | Sell |
1,933
-22,258
| -92% | -$2.02M | ﹤0.01% | 2529 |
|
|
2017
Q1 | $2.12M | Sell |
24,191
-16,765
| -41% | -$1.49M | 0.02% | 850 |
|
|
2016
Q4 | $3.39M | Buy |
40,956
+26,995
| +193% | +$2.32M | 0.03% | 648 |
|
|
2016
Q3 | $1.29M | Sell |
13,961
-18,411
| -57% | -$1.73M | 0.01% | 995 |
|
|
2016
Q2 | $2.52M | Buy |
32,372
+6,794
| +27% | +$578K | 0.02% | 717 |
|
|
2016
Q1 | $2.11M | Sell |
25,578
-47,830
| -65% | -$3.89M | 0.02% | 827 |
|
|
2015
Q4 | $7.69M | Sell |
73,408
-6,868
| -9% | -$717K | 0.05% | 279 |
|
|
2015
Q3 | $5.97M | Buy |
80,276
+27,919
| +53% | +$3.73M | 0.04% | 325 |
|
|
2015
Q2 | $7.16M | Buy |
52,357
+4,543
| +10% | +$563K | 0.05% | 275 |
|
|
2015
Q1 | $5.96M | Sell |
47,814
-977
| -2% | -$104K | 0.04% | 352 |
|
|
2014
Q4 | $4.41M | Buy |
48,791
+24,131
| +98% | +$2.01M | 0.02% | 653 |
|
|
2014
Q3 | $1.78M | Buy |
24,660
+22,619
| +1,108% | +$1.49M | 0.01% | 926 |
|
|
2014
Q2 | $127K | Sell |
2,041
-15,191
| -88% | -$918K | ﹤0.01% | 2239 |
|
|
2014
Q1 | $1.18M | Buy |
17,232
+7,357
| +75% | +$542K | 0.01% | 1073 |
|
|
2013
Q4 | $694K | Buy |
9,875
+422
| +4% | +$28.7K | ﹤0.01% | 1374 |
|
|
2013
Q3 | $683K | Buy |
+9,453
| New | +$628K | ﹤0.01% | 1454 |
|
Other funds holding BMRN
VPC
SG Americas Securities's BMRN Position: Q2 2026 in Review
SG Americas Securities reduced its BioMarin Pharmaceuticals (BMRN) stake by 44% in Q2 2026, selling an estimated $3.5M and leaving 83,024 shares worth $4.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1113.
SG Americas Securities first reported a position in BMRN in Q3 2013 and has held it in 50 quarters since. The position peaked at $21.3M in Q4 2025. 561 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.
- SG Americas Securities held 83,024 shares of BioMarin Pharmaceuticals worth $4.75M as of Q2 2026.
- SG Americas Securities sold 63,939 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $3.5M.
- BioMarin Pharmaceuticals made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1113 holding.
- SG Americas Securities first reported a position in BioMarin Pharmaceuticals in Q3 2013 and has held it in 50 quarters since.
- SG Americas Securities's BioMarin Pharmaceuticals position peaked at $21.3M in Q4 2025.
- 561 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.